Population pharmacokinetics of lamotrigine monotherapy in patients with epilepsy: Retrospective analysis of routine monitoring data

British Journal of Clinical Pharmacology

Volumn 43, Issue 5, 1997, Pages 457-465

  Hussein, Z ^a,b   Posner, J ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

epilepsy; lamotrigine; monotherapy; NONMEM; pharmacokinetics; population

Indexed keywords

LAMOTRIGINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASIAN; CAUCASIAN; CLINICAL TRIAL; COMPARTMENT MODEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CURVE FITTING; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 0030968695     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1997.00594.x     Document Type: Article

References (20)

1. Cheung H, Kamp D, Harris E. An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res 1992; 13: 107-112.
2. Leach MJ, Marden CM, Miller AA. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug II: neurochemical studies on the mechanism of action. Epilepsia 1986; 27: 490-497.
3. Binnie CD, Debets RMC, Engelsman M, et al. Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy. Epilepsy Res 1989; 4: 222-229.
4. Brodie MJ. Lamotrigine. Lancet 1992; 339: 1397-1400.
5. Jawad S, Richens A, Goodwin G, Yuen WC. Controlled trial of lamotrigine (Lamictal) for refractory partial seizures. Epilepsia 1989; 30: 356-363.
6. Loiseau P, Yuen AWC, Duche B, Menager T, Arnebes MC. A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures. Epilepsy Res 1990; 7: 136-145.
7. Risner ME. Multicentre, double-blind, placebo-controlled, add-on, cross-over study of lamotrigine in epileptic outpatients with partial seizures. Epilepsia 1990; 31: 619-620.
8. Sander JWAS, Patsalos RN, Oxley JP, Hamilton MJ, Yuen WC. A randomised double-blind controlled add-on trial of lamotrigine in patients with severe epilepsy. Epilepsy Res 1990; 6: 221-226.
9. Cohen AF, Land GS, Briemer DD, et al. Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans. Clin Pharmacol Ther 1987; 42: 535-541.
10. Depot M, Powell JR, Messenheimer JA, Cloutier G., Dalton MJ. Kinetic effects of multiple oral doses of acetaminophen on a single oral dose of lamotrigine. Clin Pharmacol Ther 1990; 48; 346-355.
11. Posner J, Holdich T, Crome P. Comparison of lamotrigine pharmacokinetics in young and elderly healthy volunteers. J Pharm Med 1991; 1: 121-128.
12. Yuen WC, Peck AW. Lamotrigine pharmacokinetics: oral and i.v. infusion in man. Br J Clin Pharmacol 1988; 26: 242.
13. Binnie CD, van Emde Boas W, Kasteleijn-Nolste-Trenite H, et al. Acute effects of lamotrigine (BW430C) in persons with epilepsy. Epilepsia 1986; 27: 248-254.
14. Jawad S, Yuen WC, Peck AW, et al. Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsy. Epilepsy Res 1987; 1: 194-201.
15. Ramsay RE, Pellock JM, Garnett WR, et al. Pharmacokinetics and safety of lamotrigine (Lamictal) in patients with epilepsy. Epilepsy Res 1991; 10: 191-200.
16. Posner J, Cohen AF, Land G, Winton C, Peck AW. The pharmacokinetics of lamotrigine (BW430C) in healthy subjects with unconjugated hyperbilirubinaemia (Gilbert's syndrome). Br J Clin Pharmacol 1989; 28: 117-120.
17. Wootton R, Soul-Lawton J, Rolan PE, Fook Sheung CTC, Cooper JDH, Posner J. Comparison of the pharmacokinetics of lamotrigine in patients with chronic renal failure and healthy volunteers. Br J Clin Pharmacol: in press.
18. Richens A. Pharmacokinetics of lamotrigine. In Clinical update on lamotrigine: a novel antiepileptic agent, ed. Richens A, pp. 21-27, Wells Medical Limited, Kent, 1992.
19. Beal SL, Sheiner LB. NONMEM Users guide, University of California, San Francisco, NONMEM Project Group, 1992.
20. Grasela TH, Sheiner LB. Pharmacostatistical modeling for observational data. J Pharmacokinen Biopharm 1991; 19 (June suppl.): 25s-26s.